Dallas, Texas: StockGuru announces The StockGuru Spotlight for Wednesday August 8, 2012: Applied DNA Sciences (OTCBB: APDN).

Applied DNA Sciences, Inc. (OTCBB: APDN)  a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced  that it has significantly expanded its office, production, and laboratory space and increased its personnel. The expansion reflects the company’s continued worldwide growth in production capacity, technology advancement, and global customer support. Those factors are also seen in a steady rise in shipments of its DNA products, the core technology around which the company’s authentication services are built.

The company’s brick-and-mortar footprint has increased by well over 50% over the last year. The company has added nine positions in that time.

Dr. James A. Hayward, President and CEO of APDN, pointed out that the expansion has been driven in part by product shipments. “By the end of December, 2011, we recorded a substantial increase in our monthly shipments of DNA; as a result, our last two previously announced quarters were each record-setters. Incremental demand should be sustained as new opportunities are addressed.”

Dr. Hayward concluded: “In addition to the current growth we are experiencing across the firm, our LMI-managed microchip project is leading the DOD’s Defense Logistics Agency to seriously consider mandating SigNature® DNA for microcircuits. We are confident we can support a DOD mandate and continue to source additional candidates as this effort might expand.

“In addition, the initial responses to our new product lines, smartDNA® and digitalDNA™, have been encouraging. Our management team felt it appropriate to grow our resources at this time.”

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

For more information on AURT, please visit: http://stockguru.com//tag/aurt/

What is The StockGuru Spotlight?

Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worthy of our readers attention.

StockGuru looks for potential break-out candidates in The StockGuru Spotlight.  Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage.  There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated StockGuru. Where that is the case, a proper disclosure is included below.   StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.

To feature a company in The StockGuru Spotlight please contact the Publisher at [email protected].  If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact the StockGuru Publisher John Pentony at this email address:  [email protected].

Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions.  SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. The companies that are discussed in this opinion have not approved the statements made in this release or blog post. This release or blog post contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.